Reiterated Neutral X

ILMN Illumina

Citigroup

$130 $90

Downgrades Buy Hold X

ILMN Illumina

HSBC Securities

$100

Downgrades Eq Weight Underweight X

ILMN Illumina

Barclays

$130 $100

Downgrades Buy Hold X

ILMN Illumina

TD Cowen

$177 $140

Downgrades Buy Neutral X

ILMN Illumina

Citigroup

$190 $165

Resumed Equal-Weight X

ILMN Illumina

Morgan Stanley

$156

Upgrades Hold Buy X

ILMN Illumina

HSBC Securities

$180

Upgrades Hold Buy X

ILMN Illumina

Argus

Upgrades Neutral Buy X

ILMN Illumina

Daiwa Securities

$120 $154

Upgrades Underweight Eq Weight X

ILMN Illumina

Barclays

$125

Upgrades Hold Buy X

ILMN Illumina

TD Cowen

$126 $144

Upgrades Neutral Buy X

ILMN Illumina

Citigroup

$140

Resumed Hold X

ILMN Illumina

Jefferies

$115

Downgrades Buy Hold X

ILMN Illumina

HSBC Securities

Downgrades Outperform Mkt Perform X

ILMN Illumina

TD Cowen

$144

Upgrades Sec Perform Sec Outperform X

ILMN Illumina

Scotiabank

$185

Upgrades Underperform Mkt Perform X

ILMN Illumina

Bernstein

Initiated Buy X

ILMN Illumina

Guggenheim

$155

Initiated Overweight X

ILMN Illumina

Stephens

$170

Initiated Outperform X

ILMN Illumina

Wolfe Research

$175

Downgrades Neutral Underperform X

ILMN Illumina

BofA Securities

$140 $100

Upgrades Sell Neutral X

ILMN Illumina

Citigroup

$85 $120

Downgrades Buy Hold X

ILMN Illumina

Canaccord Genuity

$210 $120

Initiated Underperform X

ILMN Illumina

Bernstein

$111

Resumed Neutral X

ILMN Illumina

JP Morgan

$235

Downgrades Buy Hold X

ILMN Illumina

Argus

Initiated Sector Perform X

ILMN Illumina

Scotiabank

$216

Downgrades Neutral Sell X

ILMN Illumina

Citigroup

$200 $180

Initiated Outperform X

ILMN Illumina

RBC Capital Mkts

$282

Upgrades Mkt Perform Outperform X

ILMN Illumina

SVB Leerink

$220 $270

Upgrades In-line Outperform X

ILMN Illumina

Evercore ISI

$170 $250

Initiated Neutral X

ILMN Illumina

Credit Suisse

$230

Downgrades Eq Weight Underweight X

ILMN Illumina

Barclays

$350 $150

Upgrades Hold Buy X

ILMN Illumina

Stifel

$480

Upgrades Underweight Eq Weight X

ILMN Illumina

Barclays

Upgrades Underperform Neutral X

ILMN Illumina

BofA Securities

Resumed Equal-Weight X

ILMN Illumina

Morgan Stanley

$425

Resumed Overweight X

ILMN Illumina

Piper Sandler

$450

Resumed Outperform X

ILMN Illumina

Cowen

$550

Upgrades Underperform In-line X

ILMN Illumina

Evercore ISI

$400

Downgrades Overweight Neutral X

ILMN Illumina

Atlantic Equities

$390

Upgrades Hold Buy X

ILMN Illumina

Canaccord Genuity

$445

Initiated Underweight X

ILMN Illumina

Barclays

$325

Upgrades Neutral Overweight X

ILMN Illumina

Piper Sandler

$340 $415

Downgrades Buy Hold X

ILMN Illumina

Canaccord Genuity

$330 $300

Downgrades Buy Underperform X

ILMN Illumina

BofA/Merrill

Initiated Outperform X

ILMN Illumina

Wolfe Research

Upgrades Neutral Buy X

ILMN Illumina

UBS

Initiated Neutral X

ILMN Illumina

UBS

Upgrades Underweight Eq-Weight X

ILMN Illumina

Morgan Stanley

Reiterated Buy X

ILMN Illumina

Canaccord Genuity

$330 $340

Upgrades Neutral Buy X

ILMN Illumina

Citigroup

Upgrades Eq-Weight Overweight X

ILMN Illumina

First Analysis Sec

$277

ILMN  Illumina, Inc.

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.